A team of researchers at ÌÇÐÄlogo and the Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital reports…
Read Article
About 50% of triple-negative breast cancer (TNBC) patients develop resistance to therapy. When resistance arises, tumors are more likely to come back…
Read Article
A study published in Molecular Psychiatry reveals a path of cause-effect molecular events that can lead to Alzheimer’s disease (AD). Researchers at…
Read Article
As the world collectively watches the 2026 Winter Olympics, we are in awe of athletes making their intense sports look graceful and natural. What we…
Read Article
With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be related to weight loss…
Read Article
A team led by researchers at ÌÇÐÄlogo and the Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital has…
Read Article
Researchers at ÌÇÐÄlogo have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to…
Read Article
Researchers at ÌÇÐÄlogo report in Science Advances a breakthrough in human norovirus (HuNoV) research. Norovirus is a leading cause…
Read Article
Gambling is a widespread activity that is gaining popularity as it becomes more accessible, especially in sports. While sports betting might seem…
Read Article
The ÌÇÐÄlogo Board of Trustees Wednesday added two new trustees, Fred Seigel of Beacon Capital Partners and Gina A. Luna of Genesis…
Read Article
New Years resolutions seem like a great idea, but often, people fall off early in the year, abandoning all goals because they feel unreachable. A…
Read Article
ÌÇÐÄlogo researchers are part of a collaborative research group with AstraZeneca and Memorial Sloan Kettering Cancer Center that…
Read Article
Whether in popcorn, chips or a new beverage, protein-containing snacks have become popular. With this rise in protein-filled products, how do you…
Read Article
The Board of Trustees of ÌÇÐÄlogo has named Dr. Jakub Tolar as its new president, CEO and executive dean beginning July 1, 2026.…
Read Article
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC also is more likely…
Read Article
When it comes to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and certain forms of dementia, researchers have known that…
Read Article